Expects To Meet 2025 Revenue Guidance - SEC Filing
12/01/2026 14:13
Jan 12 (Reuters) - Jazz Pharmaceuticals PLC JAZZ.O: JAZZ PHARMACEUTICALS PLC - EXPECTS TO MEET 2025 REVENUE GUIDANCE - SEC FILING Further company coverage: JAZZ.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jazz Pharmaceuticals
See all newsBrief: Jazz Pharmaceuticals Enters Amendment No. 4 To Credit Agreement On Sept 23, 2026
U.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
Jazz Pharma dips after upsized $1.1 bln convertible offering
Brief: Jazz Pharmaceuticals Announces Private Offering Of $1.0 Billion Of Exchangeable Senior Notes Due 2032